[Intensive care patients need blood transfusion--with limits. Risks must be weighed against potential benefit]

Area of Science:

• Critical Care Medicine
• Hematology

Background:

• Anemia is a common complication in intensive care units (ICUs), often stemming from multiple factors.
• The effectiveness of stored red blood cell transfusions for improving tissue oxygenation is debated, and transfusions carry inherent risks.
• Over 80% of ICU patients requiring extended stays receive red blood cell transfusions, highlighting its prevalence.

Purpose of the Study:

• To evaluate the safety and efficacy of a restrictive transfusion strategy in critically ill anemic patients.
• To explore the potential association between red blood cell transfusions and adverse outcomes like nosocomial infections and mortality.
• To assess the benefits of leucocyte-reduced blood products.

Main Methods:

• Review of recent data and evidence regarding anemia management in ICUs.
• Analysis of transfusion practices and patient outcomes, including infection rates and mortality.
• Comparison of restrictive versus liberal transfusion thresholds.

Main Results:

• A restrictive transfusion strategy, targeting a hemoglobin concentration of 70-90 g/L, is generally safe for most ICU patients.
• Transfusions may be linked to an increased incidence of nosocomial infections and higher mortality rates.
• Leucocyte-reduced transfusions may offer a survival or clinical benefit.

Conclusions:

• A restrictive hemoglobin threshold of 70-90 g/L is recommended for red blood cell transfusions in most ICU patients, except those with specific conditions.
• Minimizing red blood cell transfusions may reduce the risk of nosocomial infections and improve survival.
• Further research into optimal transfusion strategies and the role of leucocyte reduction is warranted.